How long should we wait with asymptomatic aortic stenosis and preserved LVEF?

Courtesy of Dr. Carlos Fava.

Asymptomatic severe aortic stenosis with preserved ventricular function is challenging. At present, it remains unclear whether we should operate or not and, according to some recent reports, neither do we know what patients will benefit from surgery.

Anillo pequeño, ¿debemos comenzar a elegir la válvula?The study looked at 1678 patients with asymptomatic or minimally asymptomatic severe aortic stenosis. 1108 of these patients (66%) presented left ventricular ejection fraction (LVEF) >60%, 331 (20%) between 55% and 59%, and 239 (14%) <55%.

 

Mean age was 76, the group that presented LVEF <55% were mostly men and had high atrial fibrillation and infarction, larger ventricular diameters and volumes and lower gradient.


Read also: Asymptomatic Severe Aortic Stenosis in the Elderly: When to Intervene.


758 patients received medical treatment: 469 (62%) with LVEF >60%, 167 (22%) with LVEF between 55-59% and 122 (16%) with LVEF <55%. On the other hand, the remaining 920 patients received surgery within 3 months after the eco-Doppler: 639 (60%) with LVEF >60%, 164 (18%) with LVEF 55-59% and 117 (13%) with LVEF <55%.

 

Survival at 5 years was 72% for patients with LVEF >60%, 74% for patients with LVEF between 55-59% and 59% for LVEF <55% (p >0.001). After multivariable analysis, no differences were found for patients with LVEF >60% and 55-59%, but there was higher mortality among patients with LVEF <55%.


Read also: Safety in Abdominal Aortic Aneurysm Surveillance Programs.


This was observed both in patients receiving surgery and in patients receiving medical treatment. LVEF <55% was the cutoff value for mortality increase.

 

Conclusion

In patients with asymptomatic severe aortic stenosis and preserved ventricular function (or with minimal symptoms at the time of diagnosis) ventricular ejection fraction <55% is a marker of poor outcome, with medical management or surgery. Therefore, we suggest considering surgery before patients reach this stage.

 

Gentileza del Dr. Carlos Fava.

 

Original Title: Relationship Between Left Ventricular Ejection Fraction and Mortality in Asymptomatic and Minimally Symptomatic Patients with Severe Aortic Stenosis.

Reference: Yohann Bohbot, et al. J Am Coll Cardiol Img 2018 Article in Press


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...

Can Coronary CT Angiography Replace Invasive Coronary Angiography in Pre-TAVI Coronary Assessment?

Coronary artery disease coexists in approximately half of patients undergoing transcatheter aortic valve implantation, making coronary assessment prior to the procedure essential. Invasive coronary...

Valve-in-Valve in Small Surgical Aortic Bioprostheses: Balloon-Expandable or Self-Expanding? Three-Year Results from the LYTEN Trial

Dysfunction of small surgical aortic bioprostheses represents a challenging scenario for transcatheter aortic valve replacement in the valve-in-valve setting, due to the higher incidence...

Can TAVI Be Safely Performed in Patients With Bicuspid Aortic Valve?

Bicuspid aortic valve (BAV) represents an anatomical challenge for transcatheter aortic valve replacement (TAVR) due to the frequent presence of elliptical annuli, fibroc calcific...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...